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Introduction and context {#s01}
========================

It is always good to take the long view when considering recent history. Some 4 to 5 billion years ago, the earth formed, and almost as soon as it cooled about 500 million years later, life emerged. For another 2 billion years, the most toxic antagonist to life, oxygen, accumulated in the atmosphere until it reached the levels we face today. Bacteria evolved the trick of harnessing oxygen, and eventually, about 1 billion years ago, an α-purple bacterium formed a symbiosis with another protist, an archeon, to create the first eukaryotic cell. The bacteria persist in us eukaryotes as thread granules (mitochondria) and service our cells with oxidative energy, lipid metabolism, the urea cycle, and oxygen detoxification. In us warmish creatures, they also provide heat, all of which, to paraphrase Bill Bryson, is nifty \[[@bib-001]\]. But 15 years ago, we first learned that these 'little tools' (organelles) have a dark side, playing a fundamental role in the predominant form of cell death in animals, known as apoptosis. The mitochondrial pathway of apoptosis, which concerns us here, exists at least throughout the vertebrates, and therefore this 'dark side' began almost 400 million years ago. In this brief overview, we concern ourselves with less than 1 year and our recent progress in understanding this mitochondrial function over the past few months ([Figure 1](#fig-001){ref-type="fig"}).

![The cast of characters\
Shown are the location of mitochondrial 'characters' and a subset of their proposed functions in the regulation of mitochondrial apoptosis and mitophagy as discussed in the text. (Top) Upon receiving an activating signal, a direct activator BH3-only protein such as Bid will transiently interact with Bax and Bcl-x~L~, causing their translocation to the outer mitochondrial membrane. Once inserted into the outer mitochondrial membrane, Bax can form homo-oligomers through BH3 domain interactions, leading to pore formation and MOMP. Bcl-x~L~ can bind to Bax via its BH3 domain and inhibit homo-oligomerization of Bax, thereby inhibiting MOMP and apoptosis. (Bottom left) The interaction between Beclin and Bcl-2 is disrupted by Nix (during erythroid maturation) or BNIP3 (under low-oxygen conditions), leading to mitophagy. (Bottom right) The locations of Hax, Omi, and Parl (known collectively as the 'HOP complex') are shown. Bax, B-cell lymphoma protein-2-associated X protein; Bcl-2, B-cell lymphoma protein-2; Bcl-x~L~, B-cell lymphoma protein-2-like-1; BH, B-cell lymphoma protein-2 homology; Bid, BH3-interacting domain death agonist; BNIP3, B-cell lymphoma protein-2/adenovirus E1B 19-kDa interacting protein-3; Hax, HCLS1-associated protein X; HIF1α, hypoxia inducible factor-1-alpha; HtrA2/Omi, high-temperature-regulated-A2; MOMP, mitochondrial outer membrane permeabilization; Nix: NIP3-like protein X; Opa1, optic atrophy-1; Parl, presenilin-associated rhomboid-like.](1757-594X-0001-0000000017-g001){#fig-001}

Major recent advances {#s02}
=====================

In the mitochondrial pathway of apoptosis, proteins in the Bcl-2 family function, primarily, to control the integrity of the outer mitochondrial membrane \[[@bib-002]\]. Two proteins, the proapoptotic effectors Bax and Bak, act to cause mitochondrial outer membrane permeabilization (MOMP), resulting in the diffusion of proteins of the intermembrane space (between the inner and outer mitochondrial membranes) into the cytosol, where one of these, cytochrome c, triggers a biochemical cascade resulting in the activation of caspase proteases and apoptotic cell death. Antiapoptotic members of the family, including Bcl-2, Bcl-x~L~, Mcl-1, and A1 ([Figure 1](#fig-001){ref-type="fig"}), prevent MOMP and thereby prevent cell death. Another subfamily, consisting of the BH3-only proteins, so called because they share only the third Bcl-2 homology (BH) region, regulates the other two types by neutralizing the antiapoptotic proteins and/or activating the effectors to promote MOMP.

Several recent papers give new insights into this process. Gavathiotis *et al*. \[[@bib-003]\] used a number of nuclear magnetic resonance (NMR) techniques to provide a snapshot of how the BH3 region of Bim, which is one of the BH3-only proteins that is thought to possess effector-activating activity, binds transiently to Bax to induce its activation. Bim appears to bind to a region of Bax opposite the 'BH groove' where, on the structurally related antiapoptotic proteins, BH3 domains normally bind. This somehow leads to oligomerization of Bax as it inserts into and disrupts the membrane. How this might happen comes from a study by Dewson *et al*. \[[@bib-004]\], who studied the other effector, Bak, and how it is triggered by another BH3-only activator, Bid. Using biochemical approaches, they showed that, upon activation, the BH3 region of Bak becomes exposed and can then insert into a BH groove-like opening in another activated Bak molecule (whose exposed BH3 domain seems to bind into the corresponding groove on the first Bak molecule). The scenario that emerges has been described in more detail elsewhere \[[@bib-005]\]. If an antiapoptotic protein, such as Bcl-x~L~, is present, oligomerization of Bax or Bak is blocked, preventing MOMP. Billen *et al*. \[[@bib-006]\] showed that, upon exposure to active Bid, both Bcl-x~L~ and Bax insert into outer mitochondrial membranes; Bcl-x~L~ does not form homo-oligomers but binds the BH3 of Bax (or presumably Bak), thereby preventing Bax homo-oligomerization and halting the process of MOMP.

The antiapoptotic Bcl-2 proteins, via their BH grooves, also bind to proteins with functions unrelated to MOMP and apoptosis. For example, the induction of HIF1α by hypoxia results in the expression of a BH3-only protein, BNIP3, which displaces the autophagy protein Beclin-1 that is bound to Bcl-2 (via a BH3-like region in Beclin) on mitochondria, and this appears to promote the removal of mitochondria by autophagy \[[@bib-007]\]. A BH3-only protein closely related to BNIP3, Nix, is also involved in autophagic removal of mitochondria during red blood cell maturation; mice lacking Nix have defective erythrocytes that harbor mitochondria \[[@bib-008],[@bib-009]\].

Mitochondria are highly dynamic organelles, routinely undergoing fission and fusion. Coincident with MOMP, mitochondria undergo extensive fission and this has been thought to play an important role in the process of MOMP. However, a recent study \[[@bib-010]\] showed that while Bcl-x~L~ effectively blocks MOMP, it does not necessarily prevent fission and therefore the effects are separable. An earlier study \[[@bib-011]\] had shown that depletion of Bax and Bak from cells, while preventing MOMP, promotes such fission. In light of the results of Billen *et al*. \[[@bib-006]\], discussed above, it is tempting to speculate that insertion of Bax and Bak into the membrane, even when oligomerization and MOMP are then neutralized by inserted Bcl-x~L~, nevertheless disrupts an inhibitory effect of the proapoptotic effectors (Bax and Bak) on fission. The relationship between MOMP and mitochondrial fission is further complicated by the finding that novel inhibitors of the fission protein Drp1 are effective inhibitors of MOMP \[[@bib-012]\].

While much work on MOMP and the mitochondrial pathway of apoptosis focuses on the outside of the mitochondria, events within the mitochondria appear to be involved in the process as well. A recent study \[[@bib-013]\] examined the disassembly of protein complexes of Opa1, a protein involved in mitochondrial inner membrane remodeling. The BH3-only proteins Bid or Bim, which gain access to the inner membrane space upon Bax/Bak activation and MOMP, appear to perturb Opa1, causing a subtle change in the organization of cristae junctions which facilitates cytochrome c mobilization. Intriguingly, Bak oligomerization and release of cytochrome c, but not Opa1 disassembly, were blocked by several protease inhibitors in mitochondria exposed to Bid or Bim. In another study \[[@bib-014]\], genetic ablation of three proteins of the intermembrane space (Hax1, HtrA2/Omi, and Parl) were compared. The latter two are proteases, while the former bears two BH domains (BH1 and BH2) and has previously been suggested to be antiapoptotic. All three knockout animals displayed identical developmental phenotypes, and biochemical investigation showed that Hax1 interacts with Parl to process HtrA2/Omi to function in a manner required for the survival of T lymphocytes and some neurons. Thus it seems that factors within the mitochondria may be playing an important role in the response to signals originating from outside of the mitochondria.

Future directions {#s03}
=================

Billions of years of evolution have brought us the intricate network of signaling pathways that regulate the life and death of the cell. And while 15 years of research have elucidated the importance of mitochondria for some of these pathways, there is still much to be learned. For example, the relationship between mitochondrial dynamics (that is, fission and fusion) and MOMP is still not fully elucidated, as it appears that there is a relationship between the fission machinery and MOMP, but perhaps this relationship does not involve the process of fission *per se*. In addition, regulation of MOMP from the inside of the cell is a fairly new area of research that perhaps has more unanswered questions than concrete certainties. Specifically, the relationship, if any, between the 'HOP complex' (Hax1, HtrA2/Omi, and Parl) and Opa1 is not clear. Beyond its function in HtrA2/Omi processing, Parl is thought to function in the cleavage of Opa1, but how this function (and the role of Hax1 and HtrA2/Omi in the process) relates to cellular survival remains obscure. A mutant of Opa1 that resists disassembly was found to block cytochrome c release and apoptosis \[[@bib-013]\], and it would be interesting to know whether such a mutant would protect cells lacking Hax1, HtrA2/Omi, or Parl. Thus there are still many questions to answer. It has taken us billions of years to reach this point in our story. It may take a few more years to figure out how it all works.
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A1

:   B-cell lymphoma protein-2-related protein A1

Bak

:   B-cell lymphoma protein-2-antagonist/killer-1

Bax

:   B-cell lymphoma protein-2-associated X protein

Bcl-2

:   B-cell lymphoma protein-2

Bcl-x~L~

:   B-cell lymphoma protein-2-like-1

BH

:   B-cell lymphoma protein-2 homology

Bid

:   BH3-interacting domain death agonist

Bim

:   B-cell lymphoma protein-2-like-11 (apoptosis facilitator)

BNIP3

:   B-cell lymphoma protein-2/adenovirus E1B 19-kDa interacting protein-3

Drp1

:   dynamin-related protein-1

Hax1

:   HCLS1-associated protein X-1

HIF1α

:   hypoxia inducible factor-1-alpha

HtrA2/Omi

:   high-temperature-regulated-A2

Mcl-1

:   myeloid cell leukemia sequence-1 (B-cell lymphoma protein-2-related)

MOMP

:   mitochondrial outer membrane permeabilization

Nix

:   NIP3-like protein X

Opa1

:   optic atrophy-1

Parl

:   presenilin-associated rhomboid-like
